Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs
Junjiang Sun, Wenwei Shao, Xiaojing Chen, et al.
Molecular Therapy — Methods & Clinical Development (2018) Vol. 10, pp. 257-267
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Engineering adeno-associated virus vectors for gene therapy
Chengwen Li, R. Jude Samulski
Nature Reviews Genetics (2020) Vol. 21, Iss. 4, pp. 255-272
Closed Access | Times Cited: 931
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Lindsey A. George, Margaret V. Ragni, John E.J. Rasko, et al.
Molecular Therapy (2020) Vol. 28, Iss. 9, pp. 2073-2082
Open Access | Times Cited: 159
rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
Weiran Shen, Shengjiang Liu, Li Ou
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Motahareh Arjomandnejad, Ishani Dasgupta, Terence R. Flotte, et al.
BioDrugs (2023) Vol. 37, Iss. 3, pp. 311-329
Open Access | Times Cited: 74
Advances and challenges for hemophilia gene therapy
Paul Batty, David Lillicrap
Human Molecular Genetics (2019) Vol. 28, Iss. R1, pp. R95-R101
Open Access | Times Cited: 91
Immune Response Mechanisms against AAV Vectors in Animal Models
Ashley T. Martino, David M. Markusic
Molecular Therapy — Methods & Clinical Development (2019) Vol. 17, pp. 198-208
Open Access | Times Cited: 80
Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
Kleopatra Rapti, Dirk Grimm
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48
Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
Petr O. Ilyinskii, Alicia Michaud, Christopher Roy, et al.
Science Advances (2021) Vol. 7, Iss. 9
Open Access | Times Cited: 42
A versatile toolkit for overcoming AAV immunity
Xuefeng Li, Xiaoli Wei, Jinduan Lin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients
David‐Alexandre Gross, Novella Tedesco, Christian Leborgne, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Discussing investigational AAV gene therapy with hemophilia patients: A guide
Robert F. Sidonio, Steven W. Pipe, Michael U. Callaghan, et al.
Blood Reviews (2020) Vol. 47, pp. 100759-100759
Closed Access | Times Cited: 47
Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
Liyuan Zhao, Zixuan Yang, Minhui Zheng, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 283-293
Open Access | Times Cited: 15
Emerging gene therapies for cystic fibrosis
Kamran M. Miah, Stephen C. Hyde, Deborah R. Gill
Expert Review of Respiratory Medicine (2019) Vol. 13, Iss. 8, pp. 709-725
Open Access | Times Cited: 37
Structural and cellular biology of adeno-associated virus attachment and entry
James Zengel, Jan E. Carette
Advances in virus research (2020), pp. 39-84
Closed Access | Times Cited: 33
Delivering AAV to the Central Nervous and Sensory Systems
Cole W. Peters, Casey A. Maguire, Killian S. Hanlon
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 6, pp. 461-474
Open Access | Times Cited: 29
Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
Motahareh Arjomandnejad, Katelyn Sylvia, Meghan Blackwood, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 490-506
Open Access | Times Cited: 26
Advances in delivery vectors for gene therapy in liver cancer
Katherine E. Redd Bowman, Phong Lu, Erica R. Vander Mause, et al.
Therapeutic Delivery (2019) Vol. 11, Iss. 1, pp. 833-850
Closed Access | Times Cited: 21
The Immune Response to the fVIII Gene Therapy in Preclinical Models
Seema R. Patel, Taran S. Lundgren, H. Trent Spencer, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 18
Development of Gene Therapy Vectors: Remaining Challenges
Vibhor Gupta, Sílvia Pires Lourenço, Ismael J. Hidalgo
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 5, pp. 1915-1920
Closed Access | Times Cited: 15
Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis
Amira D. Rghei, Jacob G. E. Yates, Jordyn A. Lopes, et al.
Gene Therapy (2023)
Closed Access | Times Cited: 4
Gene Therapy for Hemophilia A: Where We Stand
Miaojin Zhou, Zhiqing Hu, Chunhua Zhang, et al.
Current Gene Therapy (2020) Vol. 20, Iss. 2, pp. 142-151
Closed Access | Times Cited: 7
Gene therapy trials for haemophilia: a step closer to a cure?
Paul Batty, John Pasi
Expert Review of Precision Medicine and Drug Development (2019) Vol. 4, Iss. 5, pp. 259-262
Open Access | Times Cited: 5
Chimeric Mice Engrafted With Canine Hepatocytes Exhibits Similar AAV Transduction Efficiency to Hemophilia B Dog
Wenwei Shao, Junjiang Sun, Xiaojing Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Gene Therapy: Towards a New Era of Medicine
Meenakshi Bhagat, Raj Kamal, J. N. Sharma, et al.
AAPS PharmSciTech (2024) Vol. 26, Iss. 1
Closed Access
Adeno-associated virus neutralising antibodies in type 1 diabetes mellitus
Sławomir Andrzejewski, Aparna Murali, Charmaine A. Ramlogan‐Steel, et al.
Gene Therapy (2019) Vol. 26, Iss. 6, pp. 250-263
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top